CA1193595A - 5-cyano-prostacyclin derivatives and their manufacture and use - Google Patents

5-cyano-prostacyclin derivatives and their manufacture and use

Info

Publication number
CA1193595A
CA1193595A CA000389030A CA389030A CA1193595A CA 1193595 A CA1193595 A CA 1193595A CA 000389030 A CA000389030 A CA 000389030A CA 389030 A CA389030 A CA 389030A CA 1193595 A CA1193595 A CA 1193595A
Authority
CA
Canada
Prior art keywords
cyano
prostacyclin
tetradehydro
methyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000389030A
Other languages
English (en)
French (fr)
Inventor
Werner Skuballa
Helmut Vorbruggen
Bernd Raduchel
Jorge Casals-Stenzel
Ekkehard Schillinger
Michael H. Town
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of CA1193595A publication Critical patent/CA1193595A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015—Esters of acyclic unsaturated acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
CA000389030A 1980-10-31 1981-10-29 5-cyano-prostacyclin derivatives and their manufacture and use Expired CA1193595A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3041602.5 1980-10-31
DE19803041602 DE3041602A1 (de) 1980-10-31 1980-10-31 Neue 5-cyan-prostacyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
CA1193595A true CA1193595A (en) 1985-09-17

Family

ID=6115943

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000389030A Expired CA1193595A (en) 1980-10-31 1981-10-29 5-cyano-prostacyclin derivatives and their manufacture and use

Country Status (6)

Country Link
US (1) US4364950A (en, 2012)
EP (1) EP0051557B1 (en, 2012)
JP (1) JPS57102883A (en, 2012)
AT (1) ATE6649T1 (en, 2012)
CA (1) CA1193595A (en, 2012)
DE (2) DE3041602A1 (en, 2012)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190973A (en) * 1983-11-10 1993-03-02 Schering Aktiengesellschaft 20-alkyl-7-oxoprostacyclin derivatives useful as pharmaceuticals
JP4321511B2 (ja) 2005-10-25 2009-08-26 パナソニック株式会社 電気掃除機
CN107324986B (zh) * 2017-01-06 2021-04-30 常州博海威医药科技股份有限公司 16(s)-伊洛前列腺素的制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2729960A1 (de) * 1977-06-30 1979-01-18 Schering Ag Neue acetylenprostaglandine und verfahren zu ihrer herstellung
DE2734791A1 (de) * 1977-07-29 1979-02-15 Schering Ag Neue prostaglandin-i tief 2 -derivate und verfahren zu ihrer herstellung
DE2753244A1 (de) * 1977-11-25 1979-06-07 Schering Ag Neue prostacyclinderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
EP0051557B1 (de) 1984-03-14
JPH036145B2 (en, 2012) 1991-01-29
EP0051557A1 (de) 1982-05-12
DE3162690D1 (en) 1984-04-19
JPS57102883A (en) 1982-06-26
US4364950A (en) 1982-12-21
ATE6649T1 (de) 1984-03-15
DE3041602A1 (de) 1982-06-16

Similar Documents

Publication Publication Date Title
US4692464A (en) Novel prostacyclin derivatives and a process for the preparation thereof
US4423067A (en) Carbacyclins, their preparation and use
US4446147A (en) Azaprostacyclins, their preparation and pharmaceutical use
US4191694A (en) Prostaglandin-I2 derivatives
EP0054795B1 (en) Novel halogenated prostacyclins, process for the production thereof, and pharmaceutical use thereof
US4649156A (en) 6-nitroprostaglandin derivatives
CA1205467A (en) Prostacyclin derivatives and their manufacture and use
US4466980A (en) Thiaprostaglandin E1 derivatives, process for production thereof, and pharmaceutical use thereof
CA1193595A (en) 5-cyano-prostacyclin derivatives and their manufacture and use
IE57233B1 (en) Novel carbacyclins,process for their manufacture and their use as medicaments
WO1992018473A1 (fr) Analogue de prostaglandine e¿1?
US4552875A (en) Novel carbacyclinamides, their preparation and use as medicinal agents
JPH0368849B2 (en, 2012)
CA2073462A1 (en) 9-halogen-11beta-hydroxy-prostaglandin derivatives, process for their production and their use as pharmaceutical agents
US4532236A (en) Certain prostacyclins and their blood-pressure-lowering and thrombocyte-aggregation-inhibiting compositions and methods
US4359581A (en) Process for the production of caracyclin intermediates
US4315032A (en) Process for preparation of adjacently disubstituted ketones
US5625067A (en) Cyclopentane ether derivatives, processes for their production, and their pharmaceutical use
JPH0123445B2 (en, 2012)
CA1072956A (en) Pharmaceutically useful prostenoic acid derivatives
CA1202968A (en) Process for the preparation of new cis-bi- cyclo[3.3.0]octane derivatives
CA1290331C (en) Prostacyclins and pharmaceuticals containing the same
CA1060007A (en) 2a,2b-dihomo-16,16-dimethyl-prostaglandin analogs
US4906663A (en) 6-fluoroprostaglandins
US5124343A (en) Carbacyclins, process for the preparation thereof, and use thereof as medicinal agents

Legal Events

Date Code Title Description
MKEX Expiry